Bradlee Heckmann

Dr. Bradlee Heckmann

Department of Molecular Medicine, USF Health Byrd Alzheimer's Institute, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2020 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
EBEmilio Boada-Romero
Emilio Boada-Romero
JMJennifer Martinez
Jennifer Martinez
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
DGDouglas R. Green
Douglas R. Green

1 July 2019 in Cell
Verified
Journal Article
Closed access
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
BTBrett J.W. Teubner
Brett J.W. Teubner
BTBart Tummers
Bart Tummers
EBEmilio Boada-Romero
Emilio Boada-Romero
LHLacie Harris
Lacie Harris
DGDouglas R. Green
Douglas R. Green

1 November 2017 in Journal of Molecular Biology
Verified
Journal Article
Closed access
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
EBEmilio Boada-Romero
Emilio Boada-Romero
LCLarissa D. Cunha
Larissa D. Cunha
JMJoelle Magne
Joelle Magne
DGDouglas R. Green
Douglas R. Green

28 October 2022 in Science Advances
Verified
Journal Article
Open access
CPCarolina Peña-Martinez
Carolina Peña-Martinez
ARAlexis D. Rickman
Alexis D. Rickman
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
Noncanonical functions of the autophagy machinery in pathways including LC3-associated phagocytosis and LC3-associated endocytosis have garnered increasing interest in both normal physiology and pathobiology. New discoveries over the past decade of noncanonical uses of the autophagy machinery in these distinct molecular mechanisms have led to robust investigation into the roles of single-membrane LC3 lipidation. Noncanonical autophagy pathways have now been implicated in the regulation of multiple processes ranging from debris clearance, cellular signaling, and immune regulation and inflammation. Accumulating evidence is demonstrating roles in a variety of disease states including host-pathogen responses, autoimmunity, cancer, and neurological and neurodegenerative pathologies. Here, we broadly summarize the differences in the mechanistic regulation between autophagy and LAP and LANDO and highlight some of the key roles of LAP and LANDO in innate immune function, inflammation, and disease pathology.

20 February 2019 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
DGDouglas R. Green
Douglas R. Green
Classically, canonical autophagy has been considered a survival mechanism initiated in response to nutrient insufficiency. We now understand that autophagy functions in multiple scenarios where it is necessary to maintain homeostasis. Recent evidence has established that a variety of non-canonical functions for autophagy proteins are mechanistically and functionally distinct from autophagy. LC3-associated phagocytosis (LAP) is one such novel function for autophagy proteins and is a contributor to immune regulation and inflammatory responses across various cell and tissue types. Characterized by the conjugation of LC3 family proteins to phagosome membranes, LAP uses a portion of the canonical autophagy machinery, following ligation of surface receptors that recognize a variety of cargos including pathogens, dying cells, soluble ligands and protein aggregates. However, instead of affecting canonical autophagy, manipulation of the LAP pathway in vivo alters immune activation and inflammatory responses. In this Cell Science at a Glance article and the accompanying poster, we detail the divergence of this distinctive mechanism from that of canonical autophagy by comparing and contrasting shared and unique components of each pathway.

1 February 2013 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
Bradlee HeckmannBradlee Heckmann
Bradlee Heckmann
XZXiaodong Zhang
Xiaodong Zhang
XXXitao Xie
Xitao Xie
JLJun Liu
Jun Liu